Natus Medical (BABY)
Natus Medical Dividend Yield: 0.00%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BABY Dividend Yield Rankings
| Overall | 57th percentile | 1998 of 4657 |
| Sector | 85th percentile | 77 of 525 in Healthcare |
| Industry | 83rd percentile | 13 of 79 in Medical Appliances & Equipment |
BABY Dividend Yield Range, Past 5 Years
| Minimum | 0.00% | Jun 2007 |
| Maximum | 0.00% | Jun 2007 |
| Average | 0.00% |
About Dividend Yield
The dividend yield is the sum company's annual dividends per share, divided by the current price per share. It is often expressed as a percentage. It the reciprocal of the price/dividend ratio. By investing in a company with a high dividend yield, investors can secure a relatively stable cash flow. However, it is important to note that sometimes dividend yields are high when a company is facing financial trouble, and the company may cut the dividend in the near future.
For example, if a stock trades at $36 and pays $1.80 in dividends over the course of one year ($.45 per quarter), the company's dividend yield is 5%.
Learn More
You may also be interested in these BABY related companies
BABY News
Got out $GT at 12.15. +1.05. Jumped in $BABY few days ago at 11. Holding $HD since 50.6. Will be osting more great picks as they set up.
about 30 days ago by traderNC
about 30 days ago by traderNC
Listen to $BABY Q1 2012 earnings call - live at 11:00 AM, ondemand after - http://stks.co/3WtX
about 31 days ago by earningscast
about 31 days ago by earningscast
Listen to $BABY CareFusion to Sell Neurodiagnostic Business to Natus Medical for - live at 09:00 AM, ondemand after - http://stks.co/3SYD
about 34 days ago by earningscast
about 34 days ago by earningscast
Carefusion (CFN) to Sell Natus Medical (BABY) Its Neurodiagnostic Unit for $58M; BABY Shares Halted
Apr 23, 7:05AM Street Insider
Apr 23, 7:05AM Street Insider
CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
Apr 23, 7:00AM PR Newswire
Apr 23, 7:00AM PR Newswire
Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26
Apr 17, 7:00AM Business Wire
Apr 17, 7:00AM Business Wire
$BABY http://stks.co/2tg0 would like some consolidation on the intraday chart before a breakout... long setup
about 72 days ago by stt2318
about 72 days ago by stt2318
Listen to $BABY Q4 2011 earnings call - live at 11:00 AM, ondemand after - http://stks.co/2avH
about 89 days ago by earningscast
about 89 days ago by earningscast
UPDATE: Natus Medical Posts Weaker-Than-Expected Q4 Profit, Issues Downbeat Q1 Forecast
Feb 28, 9:34AM Benzinga
Feb 28, 9:34AM Benzinga
Natus Medical, Inc. (BABY) Misses Q4 EPS by 1c, Offers Q1 and FY12 Outlook
Feb 28, 7:08AM Street Insider
Feb 28, 7:08AM Street Insider
Natus Medical to Hold 2011 Fourth Quarter Financial Results Conference Call on February 28
Feb 21, 3:04PM Business Wire
Feb 21, 3:04PM Business Wire
$BABY - Highest close since Aug 2011 with volume perking???? http://chart.ly/dp97jg4
about 131 days ago by exkapie
about 131 days ago by exkapie
Natus Medical Announces 2012 Annual and First Quarter Financial Guidance
Jan 09, 7:00AM Business Wire
Jan 09, 7:00AM Business Wire
$BABY http://stks.co/1ouh Go BABY Go! Real nice "W-A Pattern. MACD above 0 Line. Nice trend. Prior resistance now support.
about 141 days ago by Fibline
about 141 days ago by Fibline
$BABY http://stks.co/1W0o Long setup: Tight price action & RSI flashed into higher high yesterday. Over 8.62
about 166 days ago by ToddinFL
about 166 days ago by ToddinFL
Natus Medical, Inc. (BABY) Reports In-Line Q3 EPS; Guides Q4, FY11 EPS ,Revs
Oct 27, 8:18AM Street Insider
Oct 27, 8:18AM Street Insider
$BABY prelim. Q3 sales $51.5M, down from $58M previously, vs. cons. $57.88M; sees Q4 adj-EPS 15c, down from prior 19-20c, vs. cons. 19c
about 231 days ago by Street_Insider
about 231 days ago by Street_Insider
$SQNM trisomy21 test in newspapers all over europe http://stks.co/61B http://stks.co/61C $ILMN $LIVE $CALP $BABY
about 264 days ago by biotech
about 264 days ago by biotech
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BABY | 11.22 | +0.02 | +0.18% | 330.32M |
| BAB | 29.70 | +0.01 | +0.03% | |
| BAA | 4.37 | +0.16 | +3.80% | 875.27M |
| BA | 70.00 | -1.39 | -1.95% | 52.35B |
| B | 23.08 | -0.49 | -2.08% | 1.251B |
| AZZ | 53.48 | -0.03 | -0.06% | 672.78M |
| AZPN | 21.95 | +0.05 | +0.23% | 2.057B |
| AZO | 374.37 | +4.97 | +1.35% | 14.74B |
| AZN | 41.23 | +0.05 | +0.12% | 53.28B |
| AVA | 25.45 | -0.04 | -0.16% | 1.490B |
